INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2006

Pomegranate juice lengthened prostate-specific antigen doubling time in men after prostate cancer therapy.

A phase II clinical trial evaluated daily intake of eight ounces of pomegranate juice in men with rising prostate-specific antigen following prostate cancer surgery or radiation. Treatment significantly increased average prostate-specific antigen doubling time from 15 months at baseline to 54 months posttreatment (p < 0.001). Patient serum also displayed decreased prostate cancer cell proliferation, increased apoptosis, and reduced lipid oxidation markers in laboratory assays.

Study type
Phase II clinical trial
Who was studied
Men with rising prostate-specific antigen following prostate cancer surgery or radiotherapy
What was measured
Prostate-specific antigen doubling time and serum-induced cancer cell proliferation

THE PAPER

Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer.

Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A. Clin Cancer Res, 2006.

PubMed 16818701 ↗DOI 10.1158/1078-0432.CCR-05-2290 ↗

Cancer

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.